Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluoroucil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.

C.M. van Herpen; R.L.H. Jansen; W.H. Kruit; K. Hoekman; G. Groenewegen; S Osanto; P.H. de Mulder

doi:10.1054/bjoc.1999.0997

Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluoroucil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.

Translated title of the contribution: Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluoroucil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.

C.M. van Herpen
, R.L.H. Jansen
, W.H. Kruit
, K. Hoekman
, G. Groenewegen
, S Osanto
, P.H. de Mulder

Division Imaging & Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluoroucil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
Original language	Undefined/Unknown
Pages (from-to)	772-6
Number of pages	5
Journal	British Journal of Cancer
Volume	82
Issue number	4
DOIs	https://doi.org/10.1054/bjoc.1999.0997
Publication status	Published - 2000

Access to Document

10.1054/bjoc.1999.0997

Cite this

van Herpen, C. M., Jansen, R. L. H., Kruit, W. H., Hoekman, K., Groenewegen, G., Osanto, S., & de Mulder, P. H. (2000). Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluoroucil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party. British Journal of Cancer, 82(4), 772-6. https://doi.org/10.1054/bjoc.1999.0997

@article{fd081beeeebe48e7878bf524d4d038fc,

title = "Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluoroucil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.",

author = "\{van Herpen\}, C.M. and R.L.H. Jansen and W.H. Kruit and K. Hoekman and G. Groenewegen and S Osanto and \{de Mulder\}, P.H.",

year = "2000",

doi = "10.1054/bjoc.1999.0997",

language = "Undefined/Unknown",

volume = "82",

pages = "772--6",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "4",

}

van Herpen, CM, Jansen, RLH, Kruit, WH, Hoekman, K, Groenewegen, G, Osanto, S & de Mulder, PH 2000, 'Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluoroucil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.', British Journal of Cancer, vol. 82, no. 4, pp. 772-6. https://doi.org/10.1054/bjoc.1999.0997

Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluoroucil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party. / van Herpen, C.M.; Jansen, R.L.H.; Kruit, W.H. et al.
In: British Journal of Cancer, Vol. 82, No. 4, 2000, p. 772-6.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluoroucil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.

AU - van Herpen, C.M.

AU - Jansen, R.L.H.

AU - Kruit, W.H.

AU - Hoekman, K.

AU - Groenewegen, G.

AU - Osanto, S

AU - de Mulder, P.H.

PY - 2000

Y1 - 2000

U2 - 10.1054/bjoc.1999.0997

DO - 10.1054/bjoc.1999.0997

M3 - Article

SN - 0007-0920

VL - 82

SP - 772

EP - 776

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 4

ER -